|
2023
|
Invention
|
Use of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine salt... |
|
2022
|
Invention
|
Use of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine succ... |
|
|
Invention
|
H-benzo[d]imidazol-2-amine succinate salts and solvates thereof for the treatment of motor neuron... |
|
2021
|
Invention
|
Use of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine sulp... |
|
|
Invention
|
D]imidazol-2-amine sulphate salts and solvates thereof for the treatment of motor neuron diseases... |
|
|
Invention
|
Succinate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-... |
|
2020
|
G/S
|
Diagnostic preparations for science or research; diagnostic products for science or research; dia... |
|
|
G/S
|
Diagnostic preparations for science or research; diagnostic
products for science or research; di... |
|
|
G/S
|
Diagnostic preparations for use in science or research; Diagnostic products for use in science or... |
|
2019
|
Invention
|
Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2... |
|
2014
|
Invention
|
Carboline compounds usable in the treatment of neurodegenerative diseases. The present invention ... |
|
|
Invention
|
New na-substituted carboline compounds usable for the treatment of neurodegenerative diseases. Th... |
